The Role of Periostin in Angiogenesis and Lymphangiogenesis in Tumors.
Adrian WasikKatarzyna Ratajczak-WielgomasArkadiusz BadzinskiPiotr DziegielMarzenna Podhorska-OkolowPublished in: Cancers (2022)
Periostin (POSTN) is a protein that is part of the extracellular matrix (ECM) and which significantly affects the control of intracellular signaling pathways (PI3K-AKT, FAK) through binding integrin receptors (αvβ3, αvβ5, α6β4). In addition, increased POSTN expression enhances the expression of VEGF family growth factors and promotes Erk phosphorylation. As a result, this glycoprotein controls the Erk/VEGF pathway. Therefore, it plays a crucial role in the formation of new blood and lymphatic vessels, which may be significant in the process of metastasis. Moreover, POSTN is involved in the proliferation, progression, migration and epithelial-mesenchymal transition (EMT) of tumor cells. Its increased expression has been detected in many cancers, including breast cancer, ovarian cancer, non-small cell lung carcinoma and glioblastoma. Many studies have shown that this protein may be an independent prognostic and predictive factor in many cancers, which may influence the choice of optimal therapy.
Keyphrases
- signaling pathway
- pi k akt
- epithelial mesenchymal transition
- extracellular matrix
- poor prognosis
- binding protein
- cell proliferation
- endothelial cells
- vascular endothelial growth factor
- induced apoptosis
- cell cycle arrest
- transforming growth factor
- single cell
- long non coding rna
- decision making
- bone marrow
- cell migration
- wound healing
- amino acid
- small molecule
- case control
- cell death
- mesenchymal stem cells
- dna binding